HELIUS MEDICAL TECHNOLOGIES ($HSDT) posted quarterly earnings results for Q1 2026 on Friday, May 15th. The company reported earnings of -$0.29 per share, beating estimates of -$0.49 by $0.20. The company also reported revenue of $3,620,000, beating estimates of $3,468,000 by $152,000.
You can see Quiver Quantitative's $HSDT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HELIUS MEDICAL TECHNOLOGIES Hedge Fund Activity
We have seen 19 institutional investors add shares of HELIUS MEDICAL TECHNOLOGIES stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KATHMERE CAPITAL MANAGEMENT, LLC added 4,594,960 shares (+inf%) to their portfolio in Q1 2026, for an estimated $7,949,280
- PANTERA CAPITAL PARTNERS LP removed 3,887,319 shares (-50.0%) from their portfolio in Q4 2025, for an estimated $11,234,351
- POLAR ASSET MANAGEMENT PARTNERS INC. removed 1,946,553 shares (-89.3%) from their portfolio in Q4 2025, for an estimated $5,625,538
- ARISTEIA CAPITAL, L.L.C. removed 1,089,957 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,149,975
- VANGUARD GROUP INC added 488,208 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,410,921
- CITADEL ADVISORS LLC removed 366,368 shares (-50.3%) from their portfolio in Q4 2025, for an estimated $1,058,803
- FRANCHISE GP LTD removed 226,100 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $391,153
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
